| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.42 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |